Placebo for Capivasertib, PACLITAXEL, Capivasertib, Capivasertib
D3614C00001
Phase 3 small_molecule active
Quick answer
Placebo for Capivasertib, PACLITAXEL, Capivasertib, Capivasertib for Triple-negative Breast Cancer is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Triple-negative Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active